MHC-binding peptides for immunotherapy ofexperimental autoimmune disease

This publication has 17 references indexed in Scilit:

• The T Lymphocyte in Experimental Allergic Encephalomyelitis
  Annual Review of Immunology, 1990
• MHC control of CD4+ T cell subset activation.
  The Journal of Experimental Medicine, 1989
• Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy
  Cell, 1989
• Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens.
  The Journal of Experimental Medicine, 1988
• Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy
  Cell, 1988
• Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention
  Cell, 1988
• Interaction of peptide antigens and class II major histocompatibility complex antigens
  Nature, 1986
• Peptides related to the antigenic determinant block T cell recognition of the native protein as processed by antigen‐presenting cells
  European Journal of Immunology, 1986
• Binding of immunogenic peptides to Ia histocompatibility molecules
  Nature, 1985
• Inhibition of antigen-specific T lymphocyte activation by structurally related Ir gene-controlled polymers. Evidence of specific competition for accessory cell antigen presentation.
  The Journal of Experimental Medicine, 1983